Trial Profile
A study to evaluate the treatment response to fingolimod in multiple sclerosis patients with and without prior treatment with natalizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 25 Nov 2016 New trial record